Printer Friendly
The Free Library
19,573,952 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

CEO INTERVIEW: STEPHEN GALLIKER - DYAX CORPORATION (DYAX).


(PAL (1) (Programmable Array Logic) A type of programmable logic chip (PLD) that contains arrays of programmable AND gates and predefined OR gates. PALs are defined by their number of inputs and outputs; for example, a 22v10 PAL means 22 inputs and 10 outputs. 223) STEPHEN GALLIKER - DYAX CORPORATION (DYAX). Describes the company's business and its background; prospects for the industry, with positive and negative trends; competitive threats; strategic opportunities for the firm including its marketing plans and acquisition potential; management strength and organization; and the financial prospects of the firm looking forward. Sector: Biotechnology. Published date 6/2/02. Tickers featured: DYAX. Complete text approximately 3000 words. Document # PAL223.

CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board.  INTERVIEWS, The Wall Street Transcript, 67 Wall Street, NY 10005. Voice (212) 952 7433. Fax: (212) 668-9842. E-mail: transcript@twst.com.

***
COPYRIGHT 2002 Wall Street Transcript Corporation
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2002 Gale, Cengage Learning. All rights reserved.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Comment:CEO INTERVIEW: STEPHEN GALLIKER - DYAX CORPORATION (DYAX).(Brief Article)
Publication:Wall Street Transcript Digest
Article Type:Brief Article
Geographic Code:1USA
Date:Jun 10, 2002
Words:88
Previous Article:CEO INTERVIEW: MICHAEL WICK - TELIK INC (TELK).
Next Article:CEO INTERVIEW: JAMES BIANCO - CELL THERAPEUTICS INC (CTIC).
Topics:



Related Articles
Corporate Profile for Dyax Corporation, dated June 15, 2001.
Dyax Corp. Announces Third Quarter 2001 Financial Results.
Dyax Corp. Announces Fourth Quarter and Year End 2001 Financial Results.
Dyax Corp. Announces First Quarter 2002 Financial Results.
Dyax to Present Company Update At the First Annual Needham & Company Biotechnology Conference.
Cambridge Antibody and Dyax expand phage display license.
DYAX REPORTS NET LOSS FOR 4TH QTR AND YEAR-END 2002.
CEO INTERVIEW: HENRY BLAIR - DYAX CORPORATION (DYAX).
CEO INTERVIEW: HENRY BLAIR - DYAX CORPORATION (DYAX).
CEO INTERVIEW: HENRY E. BLAIR - DYAX CORP. (DYAX).

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles